E³ - Advanced Course: Hybrid Imaging
E³ 419 - Oncology
Lectures
1
Chairperson's introduction
05:00Clemens C. Cyran, Munich / DE
2
Hybrid imaging in breast cancer: FDG and beyond
23:00Geraldine Gebhart, Brussels / BE
3
Sarcoma therapy guidance by hybrid imaging
23:00Benedikt Michael Schaarschmidt, Essen / DE
4
Clinical cases: FAPI PET/CT in oncology incl. pitfalls
23:00Frederik L. Giesel, Düsseldorf / DE
5
Panel discussion: Dear FAPI, is your clinical translation taking long, or is it a feeling?
16:00Panel discussion: Dear FAPI, is your clinical translation taking long, or is it a feeling?
5 min
Chairperson's introduction
Clemens C. Cyran, Munich / Germany
23 min
Hybrid imaging in breast cancer: FDG and beyond
Geraldine Gebhart, Brussels / Belgium
- To understand the place of FDG in BC management (staging, response assessment in neoadjuvant/metastatic setting).
- To get an overview of FES PET.
- To get an overview of HER2 PET.
23 min
Sarcoma therapy guidance by hybrid imaging
Benedikt Michael Schaarschmidt, Essen / Germany
- To learn how FAPI PET will be disruptive to FDG PET imaging.
- To understand the impact of FAPI PET also in the non-oncological space.
- To understand the impact of FAPI PET in patients with chronic diseases like lung or liver fibrosis.
23 min
Clinical cases: FAPI PET/CT in oncology incl. pitfalls
Frederik L. Giesel, Düsseldorf / Germany
- To learn how FAPI PET will be disruptive to FDG PET imaging.
- To understand the impact of FAPI PET also in the non-oncological space.
- To understand the impact of FAPI PET in patients with chronic diseases like lung or liver fibrosis.
16 min
Panel discussion: Dear FAPI, is your clinical translation taking long, or is it a feeling?